.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has submitte...
.Aelis Farma's chances of getting a simple, positive choice on a $100 thousand possibility payment h...
.ProKidney has quit one of a pair of phase 3 trials for its own cell treatment for renal health cond...
.Vaxcyte unveiled what professionals named "stunning" phase 1/2 information for its 31-valent pneumo...
.Recursion has stumbled through an early exam of its own tech-enabled technique to medication revela...
.Contact it a case of good chemical make up: Acepodia, a biotech based on Nobel Prize-winning scienc...
.Practice Preciseness Medicines has racked up an additional midphase gain in epilepsy this year, wit...
.After leaving a medical hold several years back, Dyne Therapy has exposed new phase 1/2 information...
.Arrowhead Pharmaceuticals has shown its own hand in front of a prospective showdown with Ionis, pos...
.Pfizer as well as Valneva might have about 2 additional years to stand by prior to they produce the...